LONDON–(BUSINESS WIRE)–Dec 11, 2018– analysts forecast the global travel vaccines market to cultivate at a CAGR of near 10% through the forecast period, in accordance with their latest general market trends report.
This news release features multimedia. View the entire release here: https://www.businesswire.com/news/home/20181211005669/en/
Technavio has released a fresh general market trends report on the global travel vaccines market for the time 2018-2022. (Graphic: Business Wire)
Increased incidence of travel-related diseases is probably the major trends being witnessed in the . Traveling is connected with higher health threats often, regarding infectious diseases especially. The incidence of travel-related diseases such as for example yellow fever, Japanese encephalitis, Hepatitis A & E, meningitis, typhoid, tetanus, diphtheria, and cholera worldwide is increasing. Therefore, the upsurge in the incidence of travel-related diseases will result in more investments in the global travel vaccines market for the development of far better vaccines and therefore, will propel the growth of the marketplace.
This report can be acquired at a USD 1,000 discount for a restricted time only:
According to Technavio analysts, among the key factors adding to the growth of the global travel vaccines market may be the upsurge in global travel and migration:
Global travel vaccines market: Upsurge in global travel and migration
Travel by air, sea, and land have expanded globally before couple of years highly, which has led to the spread of pathogens and disease-causing vectors worldwide. Moreover, the growing contact of individuals with different animals and plants in addition has led to the movement of pathogens from their website to people. Recently, Germany reported a rise in communicable diseases following the national country granted asylum to two million refugees, from Iraq and Syria mainly. Therefore, the upsurge in global tourism and travel, along with migration, offers huge opportunities for the manufactures of vaccines to purchase the R&D of new and much more effective vaccines. Hence, that is expected to raise the growth of the global travel vaccines market.
According to a senior analyst at Technavio for research on vaccines, “From the upsurge in global travel and migration apart, the global travel vaccines market is likely to be positively influenced by the upsurge in awareness about vaccine-preventable diseases among travelers and the mandate by countries on vaccinations ahead of issuing visas.”
Global travel vaccines market: Segmentation analysis
The global travel vaccines general market trends report provides market segmentation by target disease for immunization (influenza, diphtheria, hepatitis, typhoid, polio, and yellow fever) and by region (the Americas, EMEA, and APAC). It offers an in-depth analysis of the prominent factors influencing the marketplace, including drivers, opportunities, trends, and industry-specific challenges.
The Americas region held the biggest share of the marketplace in 2017, accounting for a lot more than 64% share, accompanied by APAC and EMEA respectively. Even though APAC held the tiniest share of the marketplace in 2017, it really is likely to register the best incremental growth through the forecast period.
Looking to find out more with this market?
Technavio’s sample reports are cost-free and contain multiple parts of the report like the market size and forecast, drivers, challenges, trends, and much more.
Some of the main element topics covered in the report include:
Market ecosystemMarket characteristicsMarket segmentation analysis
Market definitionMarket forecast and size
Five Forces Analysis
Regional comparisonKey leading countries
Vendors coveredVendor classificationMarket positioning of vendorsCompetitive scenario
is really a leading global technology research and advisory company. Their research and analysis targets emerging market trends and actionable insights to greatly help businesses identify market opportunities and develop effective ways of optimize their market positions.
With over 500 specialized analysts, Technavio’s report library includes a lot more than 10,000 counting and reports, covering 800 technologies, spanning across 50 countries. Their clientele includes enterprises of most sizes, including a lot more than 100 Fortune 500 companies. This growing clientele depends on Technavio’s comprehensive coverage, extensive research, and actionable market insights to recognize opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are looking at more info, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20181211005669/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 12/11/2018 11:15 AM/DISC: 12/11/2018 11:15 AM
Copyright Business Wire 2018.